New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Unicycive Therapeutics, Inc.
UNCY
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

42M

Biotechnology

Next Earning date - 12 Nov 2024

42M

Biotechnology

Next Earning date - 12 Nov 2024

0.44USD
Shape0.03 ( 6.57%)
Market Open
favorite-chart

Relative Strenght

10
favorite-chart

Volume Buzz

-42%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

76%

Quote Panel

Shape
Updated October 28, 2024
1W 2.76 % 1M 8.58 % 3M 4.21 % 1Y -27.63 %

Key Metrics

Shape
  • Market Cap

    41.72M


  • Shares Outstanding

    94.36M


  • Share in Float

    84.53M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    0.4422


  • Average Volume

    2.23M


  • Beta

    2.348


  • Range

    0.202-1.818


  • Industry

    Biotechnology


  • Website

    https://www.unicycive.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

Nanx

P/S Ratio

-1.06x

P/B Ratio

-3.1

Debt/Equity

10788.2%

Net Margin

$-0.4

EPS

How UNCY compares to sector?

P/E Ratio

Relative Strength

Shape

UNCY

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$33M

ShapeNaN%

2025-Revenue

$0.34

Shape-523%

2025-EPS

$7M

Shape188%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Piper Sandler

initialise

Previous: Not converted

2024-04-04

Now: Overweight

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.37
vs -0.37

Q4.22

arrow
arrow

N/A

-0.35
vs -0.17

Q1.23

arrow
arrow

N/A

-0.29
vs -0.24

Q2.23

arrow
arrow

N/A

-0.29
vs -0.24

Q3.23

arrow
arrow

N/A

-0.13
vs -0.37

Q4.23

arrow
arrow

N/A

-0.16
vs -0.35

Q1.24

arrow
arrow

N/A

-0.27
vs -0.29

Q2.24

arrow
arrow

N/A

-0.15
vs -0.29

Q3.24

arrow
arrow

N/A

-0.15
vs -0.13

Q4.24

arrow
arrow

N/A

-0.14
vs -0.16

Sales GrowthShape

status-upYoY

Current

Estimates

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

951K  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

675K  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

-100%

NA  vs 951K

Q4.23

arrow
arrow

NA

-271000.00  vs NA

Q1.24

arrow
arrow

-100%

NA  vs 675K

Q2.24

arrow
arrow

NA

NA  vs NA

Q4.24

arrow
arrow

+3790%

10M  vs -271000

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-120%

-1.20
vs -0.37

Q4.22

arrow
arrow

+1144%

11.44
vs -1.20

Q1.23

arrow
arrow

-239%

-2.39
vs 11.44

Q2.23

arrow
arrow

-56%

-0.56
vs -2.39

Q3.23

arrow
arrow

-128%

-1.28
vs -0.56

Q4.23

arrow
arrow

+205%

2.05
vs -1.28

Q1.24

arrow
arrow

+86%

0.86
vs 2.05

Q2.24

arrow
arrow

-26%

-0.26
vs 0.86

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

11

11
vs 14

-21%

Q4.22

arrow
arrow

9

9
vs 11

-18%

Q1.23

arrow
arrow

13

13
vs 9

44%

Q2.23

arrow
arrow

15

15
vs 13

15%

Q3.23

arrow
arrow

16

16
vs 15

7%

Q4.23

arrow
arrow

16

16
vs 16

NA

Q1.24

arrow
arrow

23

23
vs 16

44%

Q2.24

arrow
arrow

24

24
vs 23

4%

Earnings Growth

Latest News